AAAAAA
Results: 1-25/36
Authors:
RE A
VIJAYARAGHAVAN K
BASADE MM
HE SH
GULATI SC
Citation: A. Re et al., LONG-TERM CRYOPRESERVATION - SUCCESSFUL TRILINEAGE ENGRAFTMENT AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION WITH BONE-MARROW CRYOPRESERVED FOR 7 YEARS, Journal of hematotherapy, 7(2), 1998, pp. 185-188
Authors:
JHANWARUNIYAL M
GULATI SC
Citation: M. Jhanwaruniyal et Sc. Gulati, P53 GENE MUTATION IN THE BONE-MARROW OF A PATIENT WITH DIFFUSE MIXED CELL-TYPE LYMPHOMA AT DIAGNOSIS PREDICTING EVENTUAL PROGRESSION TO LARGE-CELL LYMPHOMA, Leukemia & lymphoma, 29(3-4), 1998, pp. 415
Authors:
BOULAD F
KERNAN NA
LAQUAGLIA MP
HELLER G
LINDSLEY KL
ROSENFIELD NS
ABRAMSON SJ
GERALD WL
SMALL TN
GILLIO AP
GULATI SC
OREILLY RJ
GHAVIMI F
Citation: F. Boulad et al., HIGH-DOSE INDUCTION CHEMORADIOTHERAPY FOLLOWED BY AUTOLOGOUS BONE-MARROW TRANSPLANTATION AS CONSOLIDATION THERAPY IN RHABDOMYOSARCOMA, EXTRAOSSEOUS EWINGS-SARCOMA, AND UNDIFFERENTIATED SARCOMA, Journal of clinical oncology, 16(5), 1998, pp. 1697-1706
Authors:
GULATI SC
VANPOZNAK C
Citation: Sc. Gulati et C. Vanpoznak, PREGNANCY AFTER BONE-MARROW TRANSPLANTATION, Journal of clinical oncology, 16(5), 1998, pp. 1978-1985
Authors:
BASADE M
GULATI SC
Citation: M. Basade et Sc. Gulati, HIGH-DOSE CHEMOTHERAPY IN METASTATIC BREAST-CANCER - REPLY, Lancet, 351(9117), 1998, pp. 1733-1733
Authors:
BASADE MM
GULATI SC
Citation: Mm. Basade et Sc. Gulati, HIGH-DOSE CHEMOTHERAPY IN METASTATIC BREAST-CANCER, Lancet, 351(9100), 1998, pp. 386-387
Authors:
NATH C
GULATI SC
Citation: C. Nath et Sc. Gulati, ROLE OF CYTOKINES IN HEALING CHRONIC SKIN WOUNDS, Acta haematologica, 99(3), 1998, pp. 175-179
Authors:
THORNE AC
MALBIN KF
JAIN M
STEWART M
GULATI SC
Citation: Ac. Thorne et al., AUTOLOGOUS BONE-MARROW HARVESTING IN OUTPATIENTS, Journal of clinical anesthesia, 8(7), 1996, pp. 551-556
Authors:
GULATI SC
BENNETT C
Citation: Sc. Gulati et C. Bennett, COST-EFFECTIVENESS ANALYSIS IN GROWTH-FACTOR USE, Experimental hematology, 24(9), 1996, pp. 680-680
Authors:
GREENBERG P
ADVANI R
KEATING A
GULATI SC
NIMER S
CHAMPLIN R
KARANES C
GORIN NC
POWLES RL
SMITH A
LAMBORN K
CUFFIE C
Citation: P. Greenberg et al., GM-CSF ACCELERATES NEUTROPHIL RECOVERY AFTER AUTOLOGOUS HEMATOPOIETICSTEM-CELL TRANSPLANTATION, Bone marrow transplantation, 18(6), 1996, pp. 1057-1064
Authors:
BASADE MM
GULATI SC
Citation: Mm. Basade et Sc. Gulati, HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS BONE-MARROW STEM-CELL RESCUE IN LUNG-CANCER, Lancet, 347(9005), 1996, pp. 847-848
Authors:
BENNETT CL
GEORGE SL
VOSE JM
NEMUNAITIS JJ
ARMITAGE JL
ARMITAGE JO
GORIN NC
GULATI SC
Citation: Cl. Bennett et al., GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AS ADJUNCT THERAPY IN RELAPSED LYMPHOID MALIGNANCY - IMPLICATIONS FOR ECONOMIC-ANALYSES OFPHASE-III CLINICAL-TRIALS, Stem cells, 13(4), 1995, pp. 414-420
Authors:
GULATI SC
GELFAND R
COLEMAN M
WOLF D
Citation: Sc. Gulati et al., TREATMENT OF HODGKINS-DISEASE - SHOULD THE PUNISHMENT FIT THE CRIME, Leukemia & lymphoma, 15, 1995, pp. 27-29
Authors:
GULATI SC
BITRAN JD
Citation: Sc. Gulati et Jd. Bitran, COST-EFFECTIVENESS ANALYSIS - SLEEPING WITH AN ENEMY OR A FRIEND, Journal of clinical oncology, 13(9), 1995, pp. 2152-2154
Authors:
KUMAR L
GULATI SC
Citation: L. Kumar et Sc. Gulati, PERIPHERAL STEM-CELL TRANSPLANTATION, Lancet, 346, 1995, pp. 9-9
Authors:
KUMAR L
GULATI SC
Citation: L. Kumar et Sc. Gulati, ALPHA-INTERFERON IN CHRONIC MYELOGENOUS LEUKEMIA, Lancet, 346(8981), 1995, pp. 984-986
Authors:
JHANWARUNIYAL M
KUCHERIA K
GULATI SC
Citation: M. Jhanwaruniyal et al., IDENTIFICATION OF PH(1)-CHROMOSOME IN PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA - CORRELATION BETWEEN RESULTS OF CYTOGENETIC AND FLUORESCENT IN-SITU HYBRIDIZATION ANALYSES, Blood, 86(10), 1995, pp. 3171-3171
Authors:
GULATI SC
GOPAL R
PROWDA JB
SPANIK S
JAIN M
GOPAL A
Citation: Sc. Gulati et al., GROWTH-FACTORS AND HEMATOPOIETIC RECOVERY, Medical oncology, 11(1), 1994, pp. 1-6
Authors:
BENNETT CL
ARMITAGE JL
LESAGE S
GULATI SC
ARMITAGE JO
GORIN NC
Citation: Cl. Bennett et al., ECONOMIC-ANALYSES OF CLINICAL-TRIALS IN CANCER - ARE THEY HELPFUL TO POLICY-MAKERS, Stem cells, 12(4), 1994, pp. 424-429
Authors:
GULATI SC
NATH B
Citation: Sc. Gulati et B. Nath, LEUKEMIA AND BONE-MARROW MICROENVIRONMENT, Stem cells, 12(2), 1994, pp. 225-226
Authors:
GULATI SC
LEMOLI RM
IGARASHI T
ATZPODIEN J
Citation: Sc. Gulati et al., NEWER OPTIONS FOR TREATING DRUG-RESISTANT (MDR-CELLS USING PHOTORADIATION THERAPY() CANCER), Leukemia & lymphoma, 12(5-6), 1994, pp. 427-433
Authors:
TAFURI A
LEMOLI RM
CHEN R
GULATI SC
CLARKSON BD
ANDREEFF M
Citation: A. Tafuri et al., COMBINATION OF HEMATOPOIETIC GROWTH-FACTORS CONTAINING IL-3 INDUCE ACUTE MYELOID-LEUKEMIA CELL SENSITIZATION TO CYCLE-SPECIFIC AND CYCLE NONSPECIFIC DRUGS, Leukemia, 8(5), 1994, pp. 749-757
Authors:
GULATI SC
DUENSING S
Citation: Sc. Gulati et S. Duensing, EVALUATING THE BENEFIT OF PURGING IN STEM-CELL TRANSPLANTATION, Cancer investigation, 12(4), 1994, pp. 447-449
DID WE FOCUS ON THE MOST IMPORTANT ISSUES IN THE USE OF GROWTH-FACTORS AND STEM-CELL TRANSPLANTATION
Authors:
GULATI SC
Citation: Sc. Gulati, DID WE FOCUS ON THE MOST IMPORTANT ISSUES IN THE USE OF GROWTH-FACTORS AND STEM-CELL TRANSPLANTATION, Journal of clinical oncology, 12(4), 1994, pp. 650-652
Authors:
LEMOLI RM
TAZZARI PL
FORTUNA A
BOLOGNESI A
GULATI SC
STIRPE F
TURA S
Citation: Rm. Lemoli et al., POSITIVE SELECTION OF HEMATOPOIETIC CD34(-CELLS PROVIDES INDIRECT PURGING OF CD34(-) LYMPHOID-CELLS AND THE PURGING EFFICIENCY IS INCREASEDBY ANTI-CD2 AND ANTI-CD30 IMMUNOTOXINS() STEM), Bone marrow transplantation, 13(4), 1994, pp. 465-471